figshare
Browse
12902_2024_1555_MOESM1_ESM.pptx (10.25 MB)

Additional file 1 of First effectiveness data of lenvatinib and pembrolizumab as first-line therapy in advanced anaplastic thyroid cancer: a retrospective cohort study

Download (10.25 MB)
presentation
posted on 2024-02-22, 04:42 authored by Dominik Soll, Philip Bischoff, Anne Frisch, Marie Jensen, Zehra Karadeniz, Martina T. Mogl, David Horst, Tobias Penzkofer, Joachim Spranger, Ulrich Keilholz, Knut Mai
Supplementary material 1.

Funding

Charité - Universitätsmedizin Berlin (3093)

History

Usage metrics

    BMC Endocrine Disorders

    Categories

    Keywords

    Anaplastic thyroid cancerLenvatinibKinase inhibitorPembrolizumabCancer immunotherapy

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC